FAP and neoplasm: This subpopulation has been observed to enhance EMT and ECM remodeling, with high glycolytic activity and interactions with tumor cells and FAP+ fibroblasts contributing to metastasis and therapy resistance, particularly in liver and lymph nodes [143,144].